Trials / Active Not Recruiting
Active Not RecruitingNCT05017935
RADIANCE Continued Access Protocol
RADIANCE Continued Access Protocol (RADIANCE CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- ReCor Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in subjects with uncontrolled hypertension despite the prescription of antihypertensive medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Renal Denervation | Renal angiogram and renal denervation (Paradise ultrasound Renal Denervation System) |
Timeline
- Start date
- 2022-05-04
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2021-08-24
- Last updated
- 2024-06-17
Locations
40 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05017935. Inclusion in this directory is not an endorsement.